FDA.reportPublic FDA data

FDA label ec99ef8a-cac9-e684-e053-2995a90ab617

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
7105ba2c-4159-465e-9f2d-6ebfd13fc8bd
SPL ID
ec99ef8a-cac9-e684-e053-2995a90ab617
Version
4
Effective date
2022-11-03
Source export date
2026-09-28
Source partition
9
Source file
https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 06:03:01

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 3 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the skin Itching Acneiform eruptions Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitis Allergic contact dermititis Millaria

adverse reactions table

<table><col width="105"/><col width="239"/><col width="206"/><tbody><tr><td>Burning</td><td>Hypertrichosis</td><td>Maceration of the skin</td></tr><tr><td>Itching</td><td>Acneiform eruptions</td><td>Secondary infection</td></tr></tbody></table>

adverse reactions table

<table><col width="117"/><col width="247"/><col width="118"/><tbody><tr><td>Irritation</td><td>Hypopigmentation</td><td>Skin atrophy</td></tr><tr><td>Dryness</td><td>Perioral dermatitis</td><td>Striae</td></tr><tr><td>Folliculitis</td><td>Allergic contact dermititis</td><td>Millaria</td></tr></tbody></table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.